...
首页> 外文期刊>Circulation research: a journal of the American Heart Association >Sumoylation and regulation of cardiac gene expression.
【24h】

Sumoylation and regulation of cardiac gene expression.

机译:心脏基因表达的平等和调节。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Sumoylation is a posttranslational modification process in which SUMO proteins are covalently and reversibly conjugated to their targets via enzymatic cascade reactions. Since the discovery of SUMO-1 in 1996, the SUMO pathway has garnered increased attention due to its role in a number of important biological activities such as cell cycle progression, epigenetic modulation, signal transduction, and DNA replication/repair, as well as its potential implication in human pathogenesis such as in cancer development and metastasis, neurodegenerative disorders and craniofacial defects. The role of the SUMO pathway in regulating cardiogenic gene activity, development and/or disorders is just emerging. Our review is based on recent advances that highlight the regulation of cardiac gene activity in cardiac development and disease by the SUMO conjugation pathway.
机译:SuMoylation是一种后期改性方法,其中通过酶级联反应共价和可逆地将Sumo蛋白质与其靶向缀合。 自1996年的Sumo-1发现以来,由于其在细胞周期进展,表观遗传调制,信号转导等一项重要的生物学活动中,Sumo途径由于其在许多重要的生物学活性中的作用而增加,并且其 诸如癌症发育和转移,神经变性障碍和颅面缺陷中的潜在致病。 SUMO途径在调节心源性基因活性,发育和/或疾病方面的作用刚刚出现。 我们的审查是基于最近的进展,突出了SUMO缀合途径对心脏发育和疾病中心脏基因活性的调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号